Laddar...
Emerging role of nivolumab in the management of patients with non-small-cell lung cancer: current data and future perspectives
Immune-checkpoint inhibitors have become valuable therapies in the treatment of patients with non-small-cell lung cancer (NSCLC). Recent clinical trials have shown promising results with regard to efficacy and toxicity profiles of these agents compared to cytotoxic chemotherapy. Nivolumab was one of...
Sparad:
| I publikationen: | Onco Targets Ther |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Dove Medical Press
2017
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5533488/ https://ncbi.nlm.nih.gov/pubmed/28769573 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S97903 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|